Literature DB >> 9696630

Identification of carbohydrates on the surface membrane of pathogenic and nonpathogenic piscine haemoflagellates, Cryptobia salmositica, C. bullocki and C. catostomi (Kinetoplastida).

S Feng1, P T Woo.   

Abstract

Carbohydrates and protein glycoconjugates on the cell membranes of Cryptobia salmositica, C. bullocki and C. catostomi were analyzed using 13 highly purified lectins (unlabelled or digoxigenin/biotin labelled). No agglutinations were observed with C. salmositica, C. bullocki and C. catostomi using lectin TPA (Tetragonolobus purpureas agglutinin, for alpha-L-fucose). C. salmositica was agglutinated by 3 of 12 lectins [Con A, for alpha-man and alpha-D-glc; PSA, for alpha-man; PWM, for (glcNAc)3], while C. bullocki was agglutinated by 8 lectins and C. catostomi was agglutinated by 10 lectins. Glycoconjugate analysis with digoxigenin or biotin labelled lectins showed a species-specific staining pattern in pathogenic and nonpathogenic Cryptobia spp. The nonpathogenic C. catostomi had the strongest reaction. These results indicate that the surface carbohydrate residues and glycoconjugate compositions on Cryptobia spp. are different between species they may be related to the virulence of the parasite.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696630     DOI: 10.3354/dao032201

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  3 in total

1.  Characterisation of carbohydrate-binding sites in developmental stages of Myxobolus cerebralis.

Authors:  Martin Knaus; Mansour El-Matbouli
Journal:  Parasitol Res       Date:  2005-10-07       Impact factor: 2.289

Review 2.  Immunological and therapeutic strategies against salmonid cryptobiosis.

Authors:  Patrick T K Woo
Journal:  J Biomed Biotechnol       Date:  2009-12-21

Review 3.  To React or Not to React: The Dilemma of Fish Immune Systems Facing Myxozoan Infections.

Authors:  Astrid S Holzer; M Carla Piazzon; Damien Barrett; Jerri L Bartholomew; Ariadna Sitjà-Bobadilla
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.